Glenmark Pharmaceuticals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 46.65% of Glenmark Pharmaceuticals, FIIs hold 21.51%, DIIs hold 17.63% and the public holds 14.17%. Promoter holding was unchanged from Jun 2026.
Get an alert when Glenmark Pharmaceuticals reports results or its shareholding changes. Free account.
Promoters
46.65%
unchanged QoQ
FIIs
21.51%
+0.62 pp QoQ
DIIs
17.63%
−0.97 pp QoQ
Public
14.17%
+0.36 pp QoQ
Glenmark Pharmaceuticals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Government | Public | Shareholders |
|---|---|---|---|---|---|---|
| Sep 2026 | 46.65% | 21.51% | 17.63% | 0.04% | 14.17% | 2,08,414 |
| Jun 2026 | 46.65% | 20.89% | 18.60% | 0.04% | 13.81% | 2,11,418 |
| Mar 2026 | 46.65% | 20.35% | 19.28% | 0.04% | 13.70% | 1,96,105 |
| Dec 2025 | 46.65% | 19.20% | 20.09% | 0.04% | 14.02% | 2,01,584 |
| Sep 2025 | 46.64% | 20.73% | 18.61% | 0.04% | 13.97% | 1,98,789 |
| Jun 2025 | 46.64% | 20.62% | 17.64% | 0.04% | 15.05% | 1,90,210 |
| Mar 2025 | 46.65% | 23.15% | 14.60% | 0.04% | 15.56% | 1,92,724 |
| Dec 2024 | 46.65% | 23.51% | 13.85% | 0.04% | 15.96% | 1,95,059 |
| Sep 2024 | 46.65% | 23.05% | 13.21% | 0.04% | 17.06% | 1,93,949 |
| Jun 2024 | 46.65% | 20.98% | 13.93% | 0.04% | 18.42% | 1,92,630 |
| Mar 2024 | 46.65% | 21.38% | 13.36% | 0.04% | 18.58% | 1,99,451 |
| Dec 2023 | 46.65% | 23.71% | 10.92% | 0.04% | 18.70% | 2,09,931 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Government · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹74.43k cr, the promoter group's 46.65% stake is worth ₹34.72k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Glenmark Pharmaceuticals shareholding: common questions
What is the promoter holding in Glenmark Pharmaceuticals?
Promoters hold 46.65% of Glenmark Pharmaceuticals as of Sep 2026. Their stake was unchanged from Jun 2026.
How much do FIIs hold in Glenmark Pharmaceuticals?
Foreign institutional investors (FIIs) held 21.51% of Glenmark Pharmaceuticals in Sep 2026, +0.62 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Glenmark Pharmaceuticals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 17.63% of Glenmark Pharmaceuticals in Sep 2026, −0.97 pp versus Jun 2026.
Is the promoter holding in Glenmark Pharmaceuticals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Glenmark Pharmaceuticals.
How has Glenmark Pharmaceuticals's promoter holding changed in the last year?
Promoter holding moved from 46.64% in Sep 2025 to 46.65% in Sep 2026 (+0.01 pp).
How many shareholders does Glenmark Pharmaceuticals have?
Glenmark Pharmaceuticals had 2,08,414 shareholders in Sep 2026, compared with 2,11,418 in Jun 2026.